AC Immune to Present at the Jefferies 2025 London Healthcare Conference

Core Insights - AC Immune SA will participate in the Jefferies Global Healthcare Conference in London from November 17-20, 2025, including a fireside chat and one-on-one investor meetings [1][2] Company Overview - AC Immune SA is a clinical-stage biopharmaceutical company focused on precision therapeutics for neurodegenerative diseases, including Alzheimer's and Parkinson's diseases [3] - The company utilizes two clinically validated technology platforms, SupraAntigen® and Morphomer®, to develop a diversified pipeline of therapeutic and diagnostic programs, with candidates in Phase 2 and Phase 3 development [3] - AC Immune has established strategic partnerships with leading global pharmaceutical companies, resulting in over $4.5 billion in potential milestone payments and royalties [3]